High levels of the inflammatory cytokine IL‐6 are correlated with poor prognosis in breast cancer 17, and IL‐6 trans‐signaling has been suggested to affect directly EMT6 and 4T1 breast cancer cell aggressiveness, leading to increased metastasis 20. Here, IL6 is linked to breast carcinoma.